LONDON, Aug. 8, 2017
/PRNewswire/ -- Oppenheimer Europe Ltd. ("Oppenheimer"), a
subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), announced
today that it is establishing a Healthcare corporate finance
franchise as the Firm continues to expand its investment banking
capabilities in EMEA. The Firm has appointed Christian Luding as Managing Director and
European Head of Healthcare Investment Banking.
The franchise will further strengthen Oppenheimer's global
Healthcare Corporate Finance capabilities. Oppenheimer has a
well-established Healthcare investment banking business in the
U.S., supported by dedicated equity research covering over 100
publicly-listed healthcare companies. By making a substantial
investment to set up an experienced team in Europe, Oppenheimer can serve both its U.S.
and European clients with a fully-dedicated and deeply specialized
global Healthcare M&A and advisory practice.
The team will be led by Mr. Luding, who joins Oppenheimer with
over 15 years of investment banking experience at UBS, Lazard, and
Nomura– in both London and
New York – advising healthcare
clients on mergers, acquisitions, divestitures, and debt and equity
financings. Mr. Luding holds a Bachelor's degree from Emory University and an MBA from the NYU Stern
School of Business.
Max Lami, Chief Executive Officer
of Oppenheimer Europe said, "We are delighted that Christian has
decided to join our Firm. As a highly respected and experienced
practitioner, Christian and the team will immeasurably strengthen
our Healthcare presence in the EMEA markets. We are very proud of
our success in building a business based on deep, long-term
relationships with our clients on both sides of the Atlantic."
Robert Lowenthal, Head of US
Investment Banking at Oppenheimer & Co. Inc., commented, "As
our clients' interests have increasingly shifted to Europe with cross-border transactions, we
continue to add bankers in Europe
to supplement our U.S. capabilities. The combination of our strong
ECM and equity research platforms and senior bankers with world
class domain expertise enables us to act as trusted advisors to our
European clients in the healthcare sector."
Mr. Luding said, "I am thrilled to have the opportunity to build
a first class M&A and capital-raising advisory business
offering our European clients a superior advisory service based on
global reach, excellence in execution of transactions, and
deep-domain expertise across all healthcare verticals."
Certain statements in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements
involve a number of risks, uncertainties and other factors that
could cause actual results to differ materially, as discussed in
the Company's filings with the Securities and Exchange
Commission.
About Oppenheimer Europe
Oppenheimer Europe Ltd. is a subsidiary of Oppenheimer Holdings
(NYSE:OPY), Inc. With over 3,400 employees and more than 90 offices
around the world, Oppenheimer is a global full-service investment
bank focusing on growth sectors and premier mid-market
companies. At Oppenheimer Europe, the integrated team of
sector and product specialists provides financial services to
European based institutions and corporations across Corporate
Finance, Equities, Fixed Income, Debt Capital Markets and Portfolio
Strategy Research. For more information about Oppenheimer, please
visit www.opco.com.
View original
content:http://www.prnewswire.com/news-releases/oppenheimer-establishes-healthcare-corporate-finance-franchise-in-europe-300500483.html
SOURCE Oppenheimer Europe Ltd.